Skip to content
  • Reports
  • Podcast Subscribe
  • Log In

Now covering the global biotech industry!
Read More
Topics
  • CRISPR
  • CAR-T
  • Covid-19
  • Microbiome
  • mRNA technology
  • Gene therapy
  • CRISPR
  • CAR-T
  • Covid-19
  • Microbiome
  • mRNA technology
  • Gene therapy
  • Log In
Now covering the global biotech industry!
Read More

Home » What’s new » Genfit » Page 2

Genfit

ADVERTISEMENT
News and Trends

Why did Biotech Beat Pharma to Bring the First Gene Therapy to Market?

Pharma would seemingly best biotech in any competition. A few CEOs explain why it left the honor…

By Evelyn Warner
March 28, 2017 - 5 minutes
In Depth

Not to be Underestimated: What’s the Hype around NASH?

Since 2014, investment in Non-Alcoholic SteatoHepatitis (NASH) has taken off with a fervor reminiscent of…

By Evelyn Warner
February 7, 2017 - 10 minutes
News and Trends

The Largest Deals, Fundraising and Exits of 2016 in European Biotech

Curious about which technologies have attracted the most cash in biotech finance this year? Here's a…

By Clara Rodríguez Fernández
December 26, 2016 - 5 minutes
News and Trends

Green Light for Genfit to Tackle another Liver Disease

The FDA has cleared Genfit's IND application to treat a second liver disease with a…

By Clara Rodríguez Fernández
November 7, 2016 - 3 minutes
News and Trends

Genfit’s Non-Invasive Diagnostic could unlock the NASH Market

Genfit reinforced its leading place in the race to find a cure for NASH when…

By Clara Rodríguez Fernández
September 20, 2016 - 2 minutes
News and Trends

Beyond NASH: Genfit jumps into another Critical Liver Condition

Genfit is extending the applications of its star candidate, Elafibranor, to a second liver disease -…

By Denise Neves Gameiro
March 31, 2016 - 2 minutes
News and Trends

Genfit Has Enroled its First Patient in a NASH Phase III Trial

Genfit (France) has enroled their first patient in the highly anticipated phase III trial (RESOLVE-IT)…

By Denise Neves Gameiro
March 11, 2016 - 2 minutes
News and Trends

10 Hot European Biotechs to watch in 2016

Looking forward to 2016, I wondered which Biotechs I would watch closely. Here's my list…

By Philip Hemme
January 12, 2016 - 6 minutes
News and Trends

Infographic: The Anatomy of European Biotech

Which part of our body do European biotechs prefer to target? And how diversified are…

By Nicolas Sainte-Foie
December 10, 2015 - 1 minute
News and Trends

Interview with the CEO of Genfit – The Billion Euro Liver Biotech on its phase III NASH Drug

Interview with Jean-François Mouney (Chairman and CEO of Genfit) at the 'Liver Meeting 2015' congress…

By Dani Bancroft
November 16, 2015 - 5 minutes
News and Trends

Boehringer kindles NASH treatments with Pharmaxis’ drug acquisition

Does NASH mean anything to you? You should be vigilant about this market as it could…

By Joachim Eeckhout
May 19, 2015 - 4 minutes
  • « Previous Page
  • 1
  • 2
footer logo

Labiotech.eu is the leading digital media covering the global biotech industry.

Over 150,000 monthly visitors use it to keep an eye on the business and innovations in biotechnology. Hope you’ll enjoy reading our stories!

  • About us
  • Inside Labiotech
  • Join Us
  • Advertise
  • Contact
  • Editorial Calendar
  • Site Map
  • Linkedin
  • Twitter
  • Youtube
  • RSS Feed
Made with in Berlin. Labiotech UG, All Rights Reserved -
  • Imprint
  • Privacy Policy

Browse Topics

Search for a topic, country or company name by using the search box

    Popular topics:


    CRISPR mRNA technology CAR-T HIV Cell therapy Diabetes Microbiome Gene therapy Synthetic biology
    Labiotech.eu
    • Log In

    Topics

    • Gene Therapy
    • CRISPR
    • CAR-T
    • Covid-19
    • Microbiome
    • Diabetes
    • Cancer

    Sections

    • News and Trends
    • In Depth
    • Best in Biotech
    • Opinion
    • Interview
    • Infographics
    Show All Topics

    For Members

    • Expert Advice
    • Reports
    • Startup Scout

    More

    • About us
    • Inside Labiotech
    • Join Us
    • Advertise
    • Contact
    • Podcast
    • Biotech Events
    • Awareness Days